Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia

IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia

(2011) Katja Schmidt et al.   Journal of Cachexia Sarcopenia and Muscle

Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”

(2010) M. Muscaritoli et al.   CLINICAL NUTRITION

Kinetics of Contraction-Induced GLUT4 Translocation in Skeletal Muscle Fibers From Living Mice

(2010) H. P. M. M. Lauritzen et al.   DIABETES

Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance

(2010) V. B. Matthews et al.   DIABETOLOGIA

The Role of GH and IGF-I in Mediating Anabolic Effects of Testosterone on Androgen-Responsive Muscle

(2010) Carlo Serra et al.   ENDOCRINOLOGY

Testosterone Therapy in Women With Chronic Heart Failure

(2010) Ferdinando Iellamo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angiotensin II Inhibits Insulin-Stimulated GLUT4 Translocation and Akt Activation through Tyrosine Nitration-Dependent Mechanisms

(2010) Alfredo Csibi et al.   PLoS One

Ethical guidelines for authorship and publishing in theJournal of Cachexia, Sarcopenia and Muscle

(2010) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Cachexia as a major underestimated and unmet medical need: facts and numbers

(2010) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

(2010) Karsten Lenk et al.   Journal of Cachexia Sarcopenia and Muscle

An overview of sarcopenia: facts and numbers on prevalence and clinical impact

(2010) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Peroxisome proliferator-activated receptor-γ agonist improves skeletal muscle insulin signaling in the pregestational intrauterine growth-restricted rat offspring

(2009) Shilpa Oak et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

PPARγ and its ligands: therapeutic implications in cardiovascular disease

(2009) Luis Villacorta et al.   CLINICAL SCIENCE

Kinetics of GLUT4 Trafficking in Rat and Human Skeletal Muscle

(2009) H. K.R. Karlsson et al.   DIABETES

A Randomized Phase 1 Study of Testosterone Replacement for Patients with Low-Risk Castration-Resistant Prostate Cancer

(2009) Russell Szmulewitz et al.   EUROPEAN UROLOGY

Interactions of ghrelin signaling pathways with the GH neuroendocrine axis: a new and experimentally tested model

(2009) Clemens Wagner et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of β-catenin

(2009) Michael A Gentile et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Effect of Long-Acting Testosterone Treatment on Functional Exercise Capacity, Skeletal Muscle Performance, Insulin Resistance, and Baroreflex Sensitivity in Elderly Patients With Chronic Heart Failure

(2009) Giuseppe Caminiti et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ACE-Inhibition and Physical Function: Results From the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) Study

(2009) Matteo Cesari et al.   Journal of the American Medical Directors Association

Sex steroids deficiency impairs glucose transporter 4 expression and its translocation through defective Akt phosphorylation in target tissues of adult male rat

(2009) Thirupathi Muthusamy et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Doping and the Olympic games: the good, the bad, and the ugly

(2009) Mitja Lainscak et al.   WIENER KLINISCHE WOCHENSCHRIFT

Cachexia: Common, Deadly, With an Urgent Need for Precise Definition and New Therapies

(2008) Mitja Lainscak et al.   AMERICAN JOURNAL OF CARDIOLOGY

Growth hormone, IGF-I and insulin and their abuse in sport

(2008) R I G Holt et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cachexia: A new definition

(2008) William J. Evans et al.   CLINICAL NUTRITION

Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle

(2008) I. Nieto-Vazquez et al.   DIABETES

Growth Hormone, Insulin-Like Growth Factors, and the Skeleton

(2008) Andrea Giustina et al.   ENDOCRINE REVIEWS

Potential Role of Growth Hormone in Impairment of Insulin Signaling in Skeletal Muscle, Adipose Tissue, and Liver of Rats Chronically Treated with Arginine

(2008) Thais de Castro Barbosa et al.   ENDOCRINOLOGY

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

(2008) S. J. Pocock et al.   EUROPEAN HEART JOURNAL

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡

(2008) Kenneth Dickstein et al.   EUROPEAN JOURNAL OF HEART FAILURE

Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition

(2008) Wolfram Doehner et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Growth Hormone Signalingin Vivoin Human Muscle and Adipose Tissue: Impact of Insulin, Substrate Background, and Growth Hormone Receptor Blockade

(2008) Charlotte Nielsen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cardiac cachexia: A systematic overview

(2008) Stephan von Haehling et al.   PHARMACOLOGY & THERAPEUTICS

Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase

(2007) Yongzhong Wei et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM